Cyclacel Pharmaceuticals ... (CYCC)
0.33
-0.00 (-0.45%)
At close: Mar 03, 2025, 12:20 PM
Price Reaction to Earnings Reports
EPS Beats Estimate ●
100%
1/1
quarters Above Average
Revenue Beats Estimate ●
0%
0/1
quarters Below Average
Avg. Price Impact ●
-3.8%
Next Day Negative Trend
Volatility Impact ●
±29.5%
Range High
Impact
This table provides an overview of how a stock's price historically reacted around earnings reports. It displays key metrics like price changes over specific timeframes and Relative Strength Index (RSI).
| Report Date | -3 Days | -2 Days | -1 Day | Open | High | Low | Close | +1 Day | +2 Days | +3 Days | +1 Week | -1 Week | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug 14, 2024
(Q2) AMC Q2 2024 | 1.37 | 1.37 | 1.45 | 1.43 | 1.62 | 1.23 | 1.32 | 1.27 | 1.22 | 1.22 | 1.20 | 1.45 | ||
IV: - RSI: 40 CYCC % | -3.52% | 0.00% | 0.00% | -1.38%
| 11.72%
| -15.17%
| -8.97%
| -3.79% | -3.94% | 0% | -1.64% | -2.68% | ||
| Daily change and RSI 14 are based on the report date for BMO releases and the following day for AMC releases. | ||||||||||||||
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.